Search research articles
Contact Us
Filters
Showing results (21-30 of 380) with videos related to
Page
of 38
Sort By:
Current Opinion in Nephrology and Hypertension
|
September 3, 2011
Renal sympathetic denervation in hypertension
Michael Doumas, Charles Faselis, Vasilios Papademetriou
The American Journal of Cardiology
|
April 23, 2022
Meta-Analysis Assessing the Effect of Tirzepatide on the Risk for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus
Dimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos
The American Journal of Cardiology
|
April 6, 2022
Meta-Analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on Pulmonary Artery Pressure Indices
Dimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos
Internal and Emergency Medicine
|
March 25, 2022
"SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series" comment
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
The American Journal of Cardiology
|
March 9, 2022
Meta-Analysis Addressing the Cardiovascular Safety of Daprodustat in Patients With Chronic Kidney Disease Undergoing Dialysis or Not
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Cardiology
|
May 14, 2015
Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?
Michael Doumas, Vasilios Athyros, Asterios Karagiannis
European Journal of Internal Medicine
|
February 26, 2021
Chronic kidney disease and diabetes status do not affect efficacy of SGLT-2 inhibitors in patients with heart failure with reduced ejection fraction
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Polish Archives of Internal Medicine
|
December 23, 2021
Sodium-glucose cotransporter 2 inhibitors and heart failure decompensation: considerations on body composition and skeletal mass
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Circulation
|
July 4, 2012
Letter by Triantafyllou et al regarding article, "Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study"
Areti Triantafyllou, Panagiota Anyfanti, Michael Doumas
Diabetes, Obesity & Metabolism
|
December 15, 2020
Updated meta-analysis assessing the risk of amputation with sodium-glucose co-transporter-2 inhibitors in the hallmark cardiovascular and renal outcome trials
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Page
of 38
Search research articles
Search
Showing results (21-30 of 380) with videos related to
Sort By:
Page
of 38
Current Opinion in Nephrology and Hypertension
|
September 3, 2011
Renal sympathetic denervation in hypertension
Michael Doumas, Charles Faselis, Vasilios Papademetriou
The American Journal of Cardiology
|
April 23, 2022
Meta-Analysis Assessing the Effect of Tirzepatide on the Risk for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus
Dimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos
The American Journal of Cardiology
|
April 6, 2022
Meta-Analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on Pulmonary Artery Pressure Indices
Dimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos
Internal and Emergency Medicine
|
March 25, 2022
"SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series" comment
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
The American Journal of Cardiology
|
March 9, 2022
Meta-Analysis Addressing the Cardiovascular Safety of Daprodustat in Patients With Chronic Kidney Disease Undergoing Dialysis or Not
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Cardiology
|
May 14, 2015
Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?
Michael Doumas, Vasilios Athyros, Asterios Karagiannis
European Journal of Internal Medicine
|
February 26, 2021
Chronic kidney disease and diabetes status do not affect efficacy of SGLT-2 inhibitors in patients with heart failure with reduced ejection fraction
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Polish Archives of Internal Medicine
|
December 23, 2021
Sodium-glucose cotransporter 2 inhibitors and heart failure decompensation: considerations on body composition and skeletal mass
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Circulation
|
July 4, 2012
Letter by Triantafyllou et al regarding article, "Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study"
Areti Triantafyllou, Panagiota Anyfanti, Michael Doumas
Diabetes, Obesity & Metabolism
|
December 15, 2020
Updated meta-analysis assessing the risk of amputation with sodium-glucose co-transporter-2 inhibitors in the hallmark cardiovascular and renal outcome trials
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
Page
of 38